We previously showed that the accumulation of acylcarnitine in NAFLD-related HCC tissues was caused by downregulation of CPT2, whereas the expression of CPT2 in non-tumorous tissues was not altered by liver fibrosis10. The gene discussed is CPT2; the disease is hepatocellular carcinoma.